Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
We have cloned and characterized a human cDNA that belongs to the histone deacetylase family, which we designate as HDAC11. The predicted HDAC11 amino acid sequence reveals an open reading frame of 347 residues with a corresponding molecular mass of 39 kDa. Sequence analyses of the putative HDAC11 protein indicate that it contains conserved residues in the catalytic core regions shared by both class I and II mammalian HDAC enzymes. Putative orthologues of HDAC11 exist in primate, mouse, Drosophila, and plant. Epitope-tagged HDAC11 protein expressed in mammalian cells displays histone deacetylase activity in vitro. Furthermore, HDAC11's enzymatic activity is inhibited by trapoxin, a known histone deacetylase inhibitor. Multiple tissue Northern blot and real-time PCR experiments show that the high expression level of HDAC11 transcripts is limited to kidney, heart, brain, skeletal muscle, and testis. Epitope-tagged HDAC11 protein localizes predominantly to the cell nucleus. Co-immunoprecipitation experiments indicate that HDAC11 may be present in protein complexes that also contain HDAC6. These results indicate that HDAC11 is a novel and unique member of the histone deacetylase family and it may have distinct physiological roles from those of the known HDACs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two related classes of eukaryotic zinc-containing HDACs have been recognized based upon sequence similarity: class I (HDAC1, 2, 3, and 8) and class II (HDAC4, 5, 6, 7, 9, and 10) (Johnstone, 2002; Gao et al., 2002).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Gao et al., 2002
In the citing paper
“It has been shown to associate with HDAC6 (Gao et al., 2002; Cheng et al., 2014)”
From Histone deacetylase 11 is an ε-N-Myristoyllysine hydrolase (2018) · cites this paper as Gao et al., 2002
In the citing paper
“HDAC11 is a newly identified member of the HDAC family and thus far no known physiological function for HDAC11 has been demonstrated23.”
From The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance (2009) · cites this paper as [23]
Citations
Cites
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Research works printed but not linked: 2
- Van Lint, 1996, Gene Expr., 5, 245
- Fischle, 2001, Biochem. Cell Biol., 79, 337, 10.1139/o01-116 · DOI · Paper page
Cited by
Items 501–600 of 761
PROTACs targeting epigenetic proteins
Zhang, C., He, Y., Sun, X., Wei, W., Liu, Y., & Rao, Y. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0039 · Cited by 20
“HDACs have also been shown to have varying catalytic reactivity toward acetylated lysine, and only HDACs 1, 2, 3, and 6 have shown lysine deacetylase activity in vitro [110].”
BackgroundHistone deacetylase 6 as a novel promising target to treat cardiovascular disease
Wu, Y., Li, B., Yu, X., Liu, Y., Chui, R., Sun, K., Geng, D., & Ma, L. (2024) · Cancer Innovation · doi:10.1002/cai2.114 · Cited by 11
“Class IV HDAC consists of a single enzyme, HDAC11, which is located in the nucleus and is homologous to the yeast proteins RPD3 and HDA1 [17].”
BackgroundCoCl2 Decreases EC-SOD Expression through Histone Deacetylation in COS7 Cells
Hattori, S., Kamiya, T., Hara, H., Ninomiya, M., Koketsu, M., & Adachi, T. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00551 · Cited by 9
Biesterveld, B. E., Wakam, G. K., Kemp, M. T., Williams, A. M., Shamshad, A., O’Connell, R. L., Siddiqui, A. Z., Chtraklin, K., Bhatti, U. F., Li, Y., et al. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002677 · Cited by 9
Lu, D., Ma, Z., Huang, D., Zhang, J., Li, J., Zhi, P., Zhang, L., Feng, Y., Ge, X., Zhai, J., et al. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-403 · Cited by 10
“While it is expressed in many organs, such as the brain and heart, its function currently is poorly understood (7,8).”
Recent Development in Novel Anticancer Therapies
Weinmann, H., & Ottow, E. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00210-8 · Cited by 13
Lai, X., Li, J. Z., Lian, Z., Niu, B. L., Chen, Y., Liao, W.-Y., Liu, Z. J., & Gong, J. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.05.044 · Cited by 10
Stabilizing HDAC11 with SAHA to assay slow-binding benzamide inhibitors
Tian, Y., Lv, W., Li, X., Wang, C., Wang, D., Wang, P. G., Jin, J., & Shen, J. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.004 · Cited by 9
Identification of histone deacetylase-3 domains that interact with the orphan nuclear receptor TR2
Li, G., Franco, P. J., & Wei, L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.145 · Cited by 10
[Histone modification and regulation of chromatin function].
Koryakov, D. E. (2006) · PubMed · Cited by 11
Regulation of cardiovascular diseases by histone deacetylases and NADPH oxidases
Yan, H. M., Yin, Y., Zhou, Y., Li, Z., Li, Y., Ren, L., Wen, J., & Wang, W. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103379 · Cited by 11
“HDAC11 is expressed highly in the brain, heart, kidney, and is present in mitochondrial, nuclear, and cytoplasmic compartments depending on the tissue and cell type [92].”
BackgroundZhou, Y., Luo, Q., Gu, L., Tian, X., Zhao, Y., Zhang, Y., & Wang, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040563 · Cited by 13
“However, a coimmunoprecipitation study showed that it might be involved in the complex containing HDAC6, thus presenting in cytoplasm [30].”
Transcriptomic changes throughout post-hatch development in Gallus gallus pituitary
Pritchett, E. M., Lamont, S. J., & Schmidt, C. J. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0186 · Cited by 7
“Because HDAC11 is a unique histone deacetylase, and it is possible it has functions that are unknown or not typically associated with histone deacetylases (Gao et al. 2002).”
BackgroundChen, Y., Feng, J., Hu, Y., Wang, X., Song, W., & Zhang, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.592385 · Cited by 8
Epigenetic Regulation Mediated by Sphingolipids in Cancer
Bozzini, N., Avnet, S., Baldini, N., & Cortini, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065294 · Cited by 8
“HDACs are divided into four families: Class 1 HDACs are ubiquitously expressed, predominantly nuclear and include HDACs 1, 2, 3 and 8 [19]; Class 2a HDACs can shuttle between nucleus and cytoplasm after phosphorylation, and include HDACs 4, 5, 7 and 9 [20]; Class 2b is comprised of HDAC 6, which is cytoplasmic [21], a…”
BackgroundThe Potential Role of Histone Modifications in Glioblastoma Therapy: Review Article
Azab, M. A. (2023) · Journal of Molecular Pathology · doi:10.3390/jmp4040018 · Cited by 9
Zhou, Z., Zhong, L., Chu, X., Wan, P., Dan, W., Shao, X., Chen, S., Zhang, Z., Lu, Y., & Liu, B. (2023) · Medical Oncology · doi:10.1007/s12032-023-02196-2 · Cited by 8
“HDAC11 is a 39 kilodalton protein [22, 23], highly expressed in ovarian, prostate, and breast cancer, which maintains tumor cell viability, protecting cells against apoptosis [22, 24].”
BackgroundOmotuyi, O. I., Abiodun, M. O., Komolafe, K., Ejelonu, O. C., & Olusanya, O. (2015) · Journal of Molecular Modeling · doi:10.1007/s00894-015-2655-8 · Cited by 8
“The exact mechanism of action of HDACs is still largely unclear but multiple X-ray resolved structures have identified competitive binding as one key event.”
BackgroundInfluentialSmall Molecular Immune Modulators as Anticancer Agents
Han, Y., Zhu, L., Wu, W., Zhang, H., Hu, W., Dai, L., & Yang, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_22 · Cited by 8
Alterations of Histone Modifications in Cancer
Mercurio, C., Plyte, S. E., & Minucci, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-388415-2.00004-4 · Cited by 11
Teng, L., Li, Z., Shi, Y., Gao, Z., Yang, Y., Wang, Y., & Bi, L. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101547 · Cited by 8
Uba, A. İ., & Zengin, G. (2023) · Amino Acids · doi:10.1007/s00726-023-03249-6 · Cited by 11
“Class IV only member HDAC11, is predominantly expressed in the brain, heart, kidneys, testis, and skeletal muscles, and is localized in the nucleus (Gao et al. 2002).”
BackgroundKim, G. S., Jung, H.-E., Kim, J., & Lee, Y. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132680 · Cited by 10
“Class IV includes only HDAC11, which shows strong sequence similarity to the class I HDACs and is predominantly located in the nucleus [19].”
BackgroundRegulation of Histone Deacetylase Activities and Functions by Phosphorylation and Dephosphorylation
Seto, E., & Yang, X. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00286-2 · Cited by 10
Targeted histone deacetylase inhibition for cancer prevention and therapy
Palmieri, C., Coombes, R. C., & Vigushin, D. M. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7414-4_7 · Cited by 8
Lv, L.-Z., Wang, Z.-D., Ren, J.-J., Li, L.-H., Liu, X.-B., Li, J.-L., Zhu, H., Jiang, B., Han, Y.-P., Zhou, X.-M., et al. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2025.1722453 · Cited by 7
“…family consists of 18 isoforms categorized into four major classes (Classes I–IV) (Zhang et al., 2024; Glozak et al., 2005; Gallinari et al., 2007; Yang and Grégoire, 2005), as summarized in Table 1 (Vanaja et al., 2018; Johnstone, 2002; Gao et al., 2002; Tong et al., 2002; Hubbert et al., 2002).”
A histone deacetylase-dependent screen in yeast
Weerasinghe, S. V. W., Wambua, M. K., & Pflum, M. K. H. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.045 · Cited by 8
Histone modifications in cardiovascular disease initiation and progression
Robinson, E. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822258-4.00021-3 · Cited by 7
Li, J., Chen, X., Liu, R., Liu, X., & Shu, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129810 · Cited by 8
Liver Cancer (Hepatocellular Carcinoma)
O’Grady, S., & Lawless, M. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00012-4 · Cited by 9
TgKDAC4: A Unique Deacetylase of Toxoplasma’s Apicoplast
Fragoso, M. S. I., de Siqueira, C. D. M., Vitorino, F. N. D. L., Vieira, A. Z., Martins-Duarte, É. S., Faoro, H., da Cunha, J. P. C., Ávila, A. R., & Nardelli, S. C. (2023) · Microorganisms · doi:10.3390/microorganisms11061558 · Cited by 13
Epigenetic transitions: towards therapeutic targets
Kalebic, T. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.6.693 · Cited by 8
“HDAC11, a novel member of the HDAC family, contains conserved residues in the catalytic core regions shared by both Class I and II mammalian enzymes [27].”
BackgroundBhagat, R. P., Jyotisha, Dasgupta, I., Amin, S. A., Jakkula, P., Bhattacharya, A., Qureshi, I. A., & Gayen, S. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11217-3 · Cited by 8
“Over 80% of the protein's sequence is occupied by the catalytic domain, whereas the N-and C-terminal regions are relatively short and do not contain any identifiable protein-binding sites [8, 10].”
Ren, L., Liu, Y., Chen, D., Rong, X., Wen, J., Zheng, Z., Chen, L., He, J., Wang, W., & Lin, R. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.120026 · Cited by 8
Isoform-Selective HDAC Inhibition in Autoimmune DiseaseNicole L Regna1* and Christopher M Reilly2
Reilly, C. M. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000207 · Cited by 8
“HDAC6 in the cytoplasm [28].”
Targeting HDAC11 activity by FT895 restricts EV71 replication
Xie, H. B., Yang, E., Wang, C., Peng, C., & Ji, L. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199108 · Cited by 7
“Initially, HDAC11 is belonging to HDAC family and is classified into the sole member of the class IV HDAC (Gao et al., 2002).”
BackgroundModification and biological role of histone
Wang, W., Meng, Z., & Shi, F. (2012) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2012.00810 · Cited by 6
PXD 101 analogs with L‐phenylglycine‐containing branched cap as histone deacetylase inhibitors
Li, J., Li, X., Wang, X., Hou, J., Zang, J., Gao, S., Xu, W., & Zhang, Y. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12787 · Cited by 6
Medicinal chemistry of histone deacetylase inhibitors
Ružić, D., Djoković, N., Nikolic, K. M., & Vujić, Z. B. (2021) · Arhiv za farmaciju · doi:10.5937/arhfarm71-30618 · Cited by 6
“The class IV HDAC is comprised of the unique HDAC11 isoform (15).”
BackgroundCadet, J. L. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150121230133 · Cited by 7
“This of interest because HDAC11 contains residues shared by classes I and II HDACs [59] involved in the behavioral effects of cocaine (see above).”
BackgroundInfluentialSchröder, C., Khatri, R., Petry, S. F., & Linn, T. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1103-1900 · Cited by 6
The Potential of Histone Deacetylase Inhibitors in Lung Cancer
Aparicio, A. M. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.011 · Cited by 7
Histone Deacetylase Inhibitors in APL and Beyond
Petrie, K. R., Prodromou, N. V., & Zelent, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-34594-7_10 · Cited by 8
“Anothermember of theHDAC family, HDAC11, was recently cloned [75] but little is known about the biological function of this enzyme, except that it is mainly localized to the nucleus, has a restricted pattern of expression and associates with HDAC6.”
BackgroundQian, P., Wang, S., Zhang, T., & Wu, J. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02215-5 · Cited by 7
“Additionally, complex formation by distinct HDACs (Gao et al. 2002) possibly enhances their functions.”
A sub-milligram-synthesis protocol for in vitro screening of HDAC11 inhibitors
Tian, Y., Jin, J., Wang, C., Lv, W., Li, X., Che, X., Gong, Y., Li, Y., Li, Q., Hou, J., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.03.116 · Cited by 5
Pharmacoepigenetics of Histone Deacetylase Inhibitors in Cancer
Garmpis, N., Damaskos, C., Garmpi, A., Valsami, S. I., & Dimitroulis, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00013-9 · Cited by 9
Epigenetic Regulation of HIV-1 Persistence and Evolving Strategies for Virus Eradication
Dhamija, N., Rawat, P., & Mitra, D. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-4525-4_21 · Cited by 5
Pride, D. A., & Summers, A. R. (2018) · International Journal of Molecular Biology Open Access · doi:10.15406/ijmboa.2018.03.00078 · Cited by 5
Epigenetic Approaches to the Treatment of Renal Cell Cancer
Hong, S. H., Lee, J., Jang, E. B., Park, S. Y., Moon, H. S., & Yoon, Y. E. (2020) · Journal of Urologic Oncology · doi:10.22465/kjuo.2020.18.2.78 · Cited by 5
“and while its sequence is similar to that of classes I and II HDACs, this enzyme is relatively uncharacterized.(90) The SIRT/class III HDAC family includes SIRT1, SIRT2,”
BackgroundDiscovery and Development of Small Molecules Targeting Epigenetic Enzymes with Computational Methods
Meng, F., Wang, C., Wan, W., Lu, W., Lu, W., & Luo, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802808-7.00004-6 · Cited by 5
Natural Products for Cancer Prevention and Therapy
Bishayee, A., & Yerer-Aycan, M. B. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-311-9 · Cited by 5
Tricyclic lactam and sultam derivatives as histone deacetylase inhibitors
null (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.3.387 · Cited by 5
Epigenetic Approaches to Cancer Therapy
Saldanha, S. N., & Tollefsbol, T. O. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00007-8 · Cited by 7
Hilscher, S., Meleshin, M., Baselious, F., Bařinka, C., Sippl, W., Schutkowski, M., & Schiene‐Fischer, C. (2025) · ACS Omega · doi:10.1021/acsomega.5c08195 · Cited by 4
Molecular Structure and Function of Zinc-Dependent Histone Deacetylases
Christianson, D. W. (2026) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051424-053005 · Cited by 5
The Role of HDAC3 in Pulmonary Diseases
Li, H., Ni, M., Xue, F., Jiang, T., Wu, X., Li, C., Liang, S., Chen, T., Luo, C., & Wu, Q. (2025) · Lung · doi:10.1007/s00408-025-00798-3 · Cited by 7
Emerging role of HDAC11 in skeletal muscle biology
Chen, J., & Li, Q. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1368171 · Cited by 4
Life Extension in Drosophila by Histone Deacetylase Inhibitors
Vaiserman, A. M., & PASYUKOVA, E. G. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-18326-8_11 · Cited by 4
“Finally, HDAC Class IV is represented by a single member, HDAC11 (Gao et al. 2002).”
BackgroundEvaluating the Effect of HDAC8 Inhibition in Malignant Peripheral Nerve Sheath Tumors
Lopez, G., & Pollock, R. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6527-4_27 · Cited by 4
Arakelyan, J., Rusanov, D. A., Chang, M. R., Asaturova, A. V., Kireeva, G. S., Alshehri, M. M., Ang, W. H., & Babak, M. V. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214899 · Cited by 5
Predicting and Monitoring Responses to Epigenetic Drugs
Sheikh, S., Bekheet, M., Olzscha, H., & Thangue, N. B. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802208-5.00015-1 · Cited by 4
Cadet, J. L., Ladenheim, B., Krasnova, I. N., & Jayanthi, S. (2016) · Journal of Drug and Alcohol Research · doi:10.4303/jdar/235998 · Cited by 4
Non-Polio Enterovirus Inhibitors: Scaffolds, Targets, and Potency─What’s New?
Roux, H., Touret, F., Rathelot, P., Sciò, P., Coluccia, A., Vanelle, P., & Roche, M. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00606 · Cited by 4
Novel Azaborine-Based Inhibitors of Histone Deacetylases (HDACs)
Behringer, M., Schweipert, M., Peters, E. E., Kopranovic, A., & Meyer‐Almes, F. (2025) · Molecules · doi:10.3390/molecules30194017 · Cited by 3
“Class IV (HDAC11) combines features of both classes I and II and regulates immunity and lipid metabolism [7].”
Reversible acetylation of Hpo regulates the Hippo pathway
Lei, F., Ding, Y., Liu, Y., Li, H., Zhou, D., Ding, W., Liu, B., Sun, X., Wang, X., Zhao, Y., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2528243123 · Cited by 3
Flavonoid-Based Derivatives for Modulating Various Targets of Alzheimer’s Disease
Pandey, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_11 · Cited by 4
Wang, J., Zhou, C., Li, B., Liu, H., Zhang, H., & Liu, L. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03206-2 · Cited by 3
“HDAC11, as the sole member of Class IV HDAC, is predominantly expressed in heart, smooth muscle, kidney, and brain tissues [27, 28].”
Peek, G. W., & Tollefsbol, T. O. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0020-z · Cited by 4
“Class 4 enzymes, also zinc dependent, include HDAC11 only (Hildmann et al. 2007; Gregoretti et al. 2004; Gao et al. 2002).”
BackgroundHDACs and Their Distinct Classes
Ganai, S. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8019-8_3 · Cited by 3
Antonova, O., Rukova, B. B., Mladenov, B. S., Rangelov, S., Hammoudeh, Z., Nesheva, D. V., Staneva, R., Spasova, V., Grigorov, E. E., Hadjidekova, S. P., et al. (2020) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2020.1778528 · Cited by 3
Ganai, S. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-8179-3_3 · Cited by 3
DNA Methylation and Histone Deacetylation: Interplay and Combined Therapy in Cancer
Qiu, Y., Shabashvili, D., Li, X., Kumari, P., Chen, M., & Zajac‐Kaye, M. (2012) · InTech eBooks · doi:10.5772/35977 · Cited by 4
“nuclear proteins, including HDAC11 (Gao et al., 2002), sumoylated p300 (Girdwood et al.”
BackgroundInfluentialSadli, N., Ahmed, N., Leigh, M., Sinclair, A. J., Colin, J., & Suphioglu, C. (2011) · InTech eBooks · doi:10.5772/28135 · Cited by 3
Hanigan, T. W., Taha, T. Y., Aboukhatwa, S. M., Frasor, J. M., & Petukhov, P. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186620 · Cited by 3
Bolger, T. A., Cohen, T., & Yao, T. (2007) · Springer eBooks · doi:10.1007/978-0-387-40049-5_6 · Cited by 4
Histone Deacetylase Inhibitors: Novel Targeted Anti-Cancer Agents
Marks, P. A., & Kelly, W. K. (2005) · Springer eBooks · doi:10.1007/1-4020-3642-6_12 · Cited by 3
Targeting Histone Deacetylase as a Strategy for Cancer Prevention
Oh, H. J., Chung, E. J., Lee, S., Loaiza‐Perez, A., Sausville, E. A., & Trepel, J. B. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-767-3_43 · Cited by 3
Epigenetic transcriptional repression of tumor suppresor genes and its reversion by drugs.
Villar‐Garea, A. (2005) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 7
IGF2BP3 recognizes m6A to regulate histone-to-protamine replacement during mouse sperm development
Wang, D., Huang, Z., Zhou, Y., Chen, P., Chang, G., Ke, L., Jing, C., Yang, H., Zhao, J., Ren, S., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00659-y · Cited by 4
“It is well known that DOT1L is the sole H3K79 methyltransferase in mammals (Feng et al, 2002; Lin et al, 2023), and HDAC11 belongs to the histone deacetylases family (Gao et al, 2002; Villagra et al, 2009).”
Histones deacetylases in the epidermis: structure, functions and therapeutic implications
Van, C. N., & Lamartine, J. (2025) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2025.1711733 · Cited by 3
“HDAC11 exhibited unique characteristics and is slightly homologous to the existing HDACs (Gao et al., 2002) and was therefore classi fi ed as a member of a new and distinct class IV (Gregoretti et al., 2004).”
Recommended Tool Compounds: Isoform- and Class-Specific Histone Deacetylase Inhibitors
Schäker‐Hübner, L., & Hansen, F. K. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00619 · Cited by 5
Bree, B. A. V., & Eichner, L. J. (2026) · Science Advances · doi:10.1126/sciadv.aee7295 · Cited by 6
“Typical APL is characterized by the t(15;17) chromosome translocation that creates the promyelocytic leukemia and retinoic acid receptor-α fusion (PML::RAR α ) that dysregulates gene expression ( 62 ).”
InfluentialThomas, E. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805420-8.00007-x · Cited by 2
In Silico Discovery of Class IIb HDAC Inhibitors: The State of Art
Khatun, S., Amin, S. A., Gayen, S., & Jha, T. (2023) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-031-33871-7_2 · Cited by 2
Regulation of HDAC11 gene expression in early myogenic differentiation
Li, Q., Mach, Y. Z., Hamed, M., Khilji, S., & Chen, J. (2023) · PeerJ · doi:10.7717/peerj.15961 · Cited by 2
“HDAC11 is the only member of the class IV HDACs, the most recently identified, and is localized to the nucleus (Gao et al., 2002).”
BackgroundMcCoy, M. T., Daiwile, A. P., Ladenheim, B., & Cadet, J. L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04869-7 · Cited by 2
“HDAC11 shares a catalytic domain with class I and class II HDACs [45].”
Liu, L., Yuan, P., Doğan, S., Zhu, F., & Duan, Q. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0099-9 · Cited by 2
“Class IV HDAC contains only HDAC11, which is homologous with both class I and class II HDAC11 and expresses in specific tissues including the kidney, skeletal heart, muscle, brain, and testis [46].”
BackgroundBürli, R. W., Thomas, E. A., & Beaumont, V. (2010) · Topics in medicinal chemistry · doi:10.1007/7355_2010_10 · Cited by 3
Epigenetic and Signaling Pathway Regulation in Hair Cell Regeneration
Li, H. (2015) · Cellular & Molecular Medicine Open access · doi:10.21767/2573-5365.100006 · Cited by 5
Charlet, J., & Liang, G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800957-4.00016-3 · Cited by 2
Genetics and Epigenetics in Cancer Biology
Velcich, A., Klampfer, L., Mariadason, J. M., Smartt, H. J. M., Guilmeau, S., Maier, S. M., Yang, W., Christman, J. K., Heerdt, B. G., & Augenlicht, L. H. (2006) · Elsevier eBooks · doi:10.1016/b978-012088393-6/50059-2 · Cited by 2
ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Kraft, W. K., & Leone, F. T. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50032-9 · Cited by 2
Regulation of HDACi−Triggered Autophagy by the Tumor Suppressor Protein p53
Mrakovcic, M., & Fröhlich, L. F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86911 · Cited by 3
The Role of Epigenetics in Cardiovascular Disease
Zhou, B., Margariti, A., & Xu, Q. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-388415-2.00020-2 · Cited by 2
Bhebhe, A., Meyering, S. S., & Saldanha, S. N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18661-5.00029-4 · Cited by 2
Sahakian, E., Woan, K. V., Villagra, A., & Sotomayor, E. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00022-1 · Cited by 2
Dong, Y., & Zou, S. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_5 · Cited by 2
“HDAC11 protein is conserved only in fly, mouse, and higher organisms but not in yeast and nematode (Gao et al. 2002).”
Backgrounddos Santos, P. W. D. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2019.tde-24052019-145414 · Cited by 4
Cadet, J. L., & Jayanthi, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00089-x · Cited by 2
Epigenetic Enzymes and Their Mutations in Cancer
Dalmızrak, A., & Dalmızrak, Ö. (2023) · Epigenetics and human health · doi:10.1007/978-3-031-42365-9_2 · Cited by 1
Metadata
- Authors
- Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P.
- Affiliations
- Novartis (United States) (US)
- Corresponding author
- Atadja, Peter
- ORCID
- Gao, Lin
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 277
- Issue
- 28
- Pages
- 25748-25755
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2070089404
- Cited by
- 744
- References
- 43
- Citations by year
- 2026: 27 · 2025: 28 · 2024: 32 · 2023: 36 · 2022: 31 · 2021: 33 · 2020: 43 · 2019: 26 · 2018: 30 · 2017: 36 · 2016: 30 · 2015: 41 · 2014: 34 · 2013: 30 · 2012: 37
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6687 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- HDAC11, histone deacetylase, cDNA cloning, histone deacetylase activity, tissue expression, nuclear localization, protein complexes, evolutionary conservation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cloning, Molecular, Histone Deacetylases, Humans, Molecular Sequence Data, Nuclear Proteins, RNA, Messenger, Sequence Homology, Amino Acid, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.